<DOC>
	<DOCNO>NCT00640185</DOCNO>
	<brief_summary>The purpose study test investigational medication ABT-089 safe effective treatment adult Attention-Deficit/Hyperactivity Disorder ( ADHD ) .</brief_summary>
	<brief_title>Safety , Tolerability Efficacy Study ABT-089 Adults With Attention-Deficit/Hyperactivity Disorder ( ADHD )</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Attention Deficit Disorder Hyperactivity</mesh_term>
	<mesh_term>Hyperkinesis</mesh_term>
	<criteria>Have voluntarily sign informed consent form . Meet diagnostic criterion attentiondeficit/hyperactivity disorder ( ADHD ) base detailed evaluation interview subject . Subject generally good health base medical history , physical examination , clinical lab test ECG . Female subject childbearing potential must negative urine pregnancy test screening baseline agree comply applicable contraceptive requirement . Male subject must agree comply applicable contraceptive requirement . Subject able keep require appointment clinic visit test , include blood draw examination . Subject current past diagnosis schizoaffective disorder , schizophrenia , obsessivecompulsive disorder , druginduced psychosis , bipolar disorder , psychotic disorder . Current diagnosis major depressive disorder , generalize anxiety disorder , PTSD sleep disorder require treatment kind . Subject history , ongoing , serious medical problem . Subject history significant allergic reaction drug . Subject plan begin type behavioral psychotherapy treatment ADHD . Subject require ongoing treatment psychiatric medication .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>January 2013</verification_date>
</DOC>